Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2006 May;27(5):1096-7.

Bisphosphonate-associated mandibular osteonecrosis

Affiliations
Case Reports

Bisphosphonate-associated mandibular osteonecrosis

E Carneiro et al. AJNR Am J Neuroradiol. 2006 May.

Abstract

A 66-year-old man with multiple myeloma treated with zoledronic acid, melphalan, and prednisone after a tooth extraction developed severe osteonecrosis of the mandible that was nonresponsive to antibiotic therapy. A CT scan showed innumerable fragmented sequestra in the mandible and some adjacent soft tissue fullness around the mandible. The association between the use of bisphosphonates and osteonecrosis of the jaw has been described only recently.

PubMed Disclaimer

Figures

Fig 1.
Fig 1.
Serial axial (A and B) and coronal (CE) CT scans of the mandible show extensive fragmentation and sequestration of this edendulous mandible. There was mild adjacent soft tissue fullness. This degree of osteonecrosis would be excessive for the more common radiation-related disease.

References

    1. American Cancer Society. Cancer: facts & figures 2002. Atlanta: American Cancer Society;2002. :4
    1. Kinney MKC, Swerdlow SH. Hematopoietic and lymphoid disorders. In: Barnes L, ed. Surgical pathology of the head and neck. New York: Marcel Dekker;2001. :1326–29
    1. Kyle RA, Rajkumar SV. Multiple myeloma. N Eng J Med 2004;351:1860–73 - PubMed
    1. Berensen JR, Rosen LS, Howell A, et al. Zoledronic acid reduces skeletal-related events in patients with osteolitic metastases. Cancer 2001;91:1191–200 - PubMed
    1. Magliorati CA. Bisphosphonates and oral cavity avascular bone necrosis. J Clin Oncol 2003;21:4253–54 - PubMed

Publication types